About
Artivion is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our purpose is to develop simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with diseases of the aorta and deliver breakthrough technologies of unsurpassed quality that have far-reaching impact. Our decades of expertise in treating aortic diseases—coupled with our recent acquisitions and partnerships—have empowered us to offer cardiac and vascular surgeons a suite of aortic-centric solutions such as cryopreserved cardiac and vascular allografts, surgical sealants, prosthetic heart valves, and aortic stents and stent-grafts. Artivion has over 1,250 employees worldwide with sales representation in over 100 countries. The Company has manufacturing facilities located in Atlanta, Georgia, Austin, Texas, and Hechingen, Germany. Additionally, it has sales and distribution offices in various countries throughout Europe, Asia, and South America.
Top Deals
SOLD
Share this deal
Texas | Industrial | PPSF: $63
03/11/2026
Focus
Sale
Markets
FAQs
Artivion Inc. has financed 1 deal.
Artivion Inc.'s most recent deal was on March 11, 2026.
Artivion Inc.'s largest deals include a sale of $20,600,000.00 for 1300 East Anderson Lane.
Member since: March 2026
Deals
Transaction Type
Asset Type
State
Sort By
SOLD
Patrick Mackin Of Artivion Inc. Acquires Industrial Portfolio In Austin For $20.6M
$63/SF
1300 East Anderson Lane, Austin, TX
TXCRE
Mar 11, 2026